News
November date set for FDA decision on Sanofi's Gaucher drug
The FDA has started a priority review of Sanofi's brain-acting Gaucher disease therapy venglustat, with an action date of 25th November.
News
AbbVie's Immunogen buy delivers rare cancer drug approval
AbbVie's Decnupaz approval will give patients with rare blood cancer BPDCN an alternative to Stemline's Elzonris with a simpler dosing regimen.
News
FDA delays verdict on AZ breast cancer drug
After an advisory committee setback, AstraZeneca has a chance to make the case for its oral SERD camizestrant for breast cancer.
News
Gilead claims first FDA nod for a hepatitis D therapy
At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
News
Oral Wegovy backed by CHMP at May meeting
The CHMP recommended eight new medicines and 13 line extensions at its May meeting, including Novo Nordisk's oral weight loss therapy.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
